Related Experiment Video
Updated: Jun 11, 2025
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
A brief overview of targeted radionuclide therapy trials in 2022
Aidan Healy1, Elaine Ho2, Phillip Kuo3
1California Northstate University College of Medicine, California Northstate University, Sacramento, CA, United States.
Abstract:
There is a growing use of radionuclide therapy for the medical care of oncology patients, where radioactive pharmaceuticals are used to target and treat various cancer types. This paper provides a brief overview illustrating the spectrum of ongoing and recently completed radionuclide therapy clinical trials in oncology. The trials selected highlight the potential of radionuclide therapies to provide a promising treatment option across a spectrum of cancer patients, while also discussing the importance of patient selection and monitoring, as well as potential side effects and safety concerns. Ultimately, the results of these trials will be crucial in determining the future use of radionuclide therapies in cancer treatment.
Insights
Radionuclide therapy is increasingly used for cancer treatment. Clinical trials show its promise, but careful patient selection and monitoring are vital for safety and effectiveness.
Area of Science:
- Oncology
- Nuclear Medicine
Background:
- Radionuclide therapy utilizes radioactive pharmaceuticals to target and treat various cancer types.
- Its application in oncology is expanding, necessitating a review of current clinical research.
Purpose of the Study:
- To provide an overview of ongoing and recently completed radionuclide therapy clinical trials in oncology.
- To highlight the potential of these therapies and discuss critical factors for their successful implementation.
Main Methods:
- Review of selected clinical trials in radionuclide therapy for oncology.
- Analysis of trial outcomes focusing on efficacy, patient selection, monitoring, and safety.
Main Results:
- Selected trials demonstrate the potential of radionuclide therapies across diverse cancer types.
- Emphasis on the importance of appropriate patient selection and vigilant monitoring.
- Identification of potential side effects and safety concerns associated with radionuclide therapy.
Conclusions:
- Radionuclide therapies represent a promising treatment modality for cancer patients.
- Further trial results are essential to define the future role of radionuclide therapy in cancer care.
- Optimizing patient selection and safety protocols will be key to maximizing therapeutic benefits.
